ebomi
Colour theme
Sign in
Insider · CIK 0001790965

Column Group III GP, LP

CIK 0001790965 Name as filed on the most recent filing

Filed as Column Group III GP, LP (44)

97 transaction lines · from 44 filings · filed 2019-10-11 to 2026-02-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-08-28 P, Open-market purchase NGM Biopharmaceuticals IncNGM 467,555, acquired Open Form 4 filing 0001209191-20-048800
2020-08-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 646,827, acquired Open Form 4 filing 0001209191-20-048800
2020-08-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,800, acquired Open Form 4 filing 0001209191-20-048295
2020-08-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 197,991, acquired Open Form 4 filing 0001209191-20-048295
2020-08-21 P, Open-market purchase NGM Biopharmaceuticals IncNGM 131,558, acquired Open Form 4 filing 0001209191-20-048295
2020-08-17 P, Open-market purchase NGM Biopharmaceuticals IncNGM 114,943, acquired Open Form 4 filing 0001209191-20-046994
2020-08-14 P, Open-market purchase NGM Biopharmaceuticals IncNGM 664,498, acquired Open Form 4 filing 0001209191-20-046994
2020-08-13 P, Open-market purchase NGM Biopharmaceuticals IncNGM 355,922, acquired Open Form 4 filing 0001209191-20-046994
2020-07-30 P, Open-market purchase NGM Biopharmaceuticals IncNGM 13,169, acquired Open Form 4 filing 0001209191-20-044544
2020-07-28 P, Open-market purchase NGM Biopharmaceuticals IncNGM 73,849, acquired Open Form 4 filing 0001209191-20-044108
2020-07-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 68,974, acquired Open Form 4 filing 0001209191-20-043876
2020-07-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,232,670, acquired Open Form 4 filing 0001209191-20-043876
2020-07-22 P, Open-market purchase NGM Biopharmaceuticals IncNGM 3,474, acquired Open Form 4 filing 0001209191-20-043529
2020-04-08 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,683,400, acquired Open Form 4 filing 0001209191-20-024074
2020-04-07 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,779,209, acquired Open Form 4 filing 0001209191-20-023864
2020-04-03 P, Open-market purchase NGM Biopharmaceuticals IncNGM 181,025, acquired Open Form 4 filing 0001209191-20-023864
2020-04-02 P, Open-market purchase NGM Biopharmaceuticals IncNGM 184,140, acquired Open Form 4 filing 0001209191-20-022770
2020-04-01 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,447,501, acquired Open Form 4 filing 0001209191-20-022770
2020-03-31 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,479,380, acquired Open Form 4 filing 0001209191-20-022770
2020-03-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 30,176, acquired Open Form 4 filing 0001209191-20-021183
2020-03-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,568,767, acquired Open Form 4 filing 0001209191-20-021183
2020-03-23 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,981,601, acquired Open Form 4 filing 0001209191-20-021183
2020-03-20 P, Open-market purchase Constellation Pharmaceuticals IncCNST 128,228, acquired Open Form 4 filing 0001209191-20-020732
2020-03-20 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,684,075, acquired Open Form 4 filing 0001209191-20-020687
2020-03-19 P, Open-market purchase Constellation Pharmaceuticals IncCNST 808,701, acquired Open Form 4 filing 0001209191-20-020732
2020-03-19 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,720,698, acquired Open Form 4 filing 0001209191-20-020687
2020-03-05 P, Open-market purchase NGM Biopharmaceuticals IncNGM 149,526, acquired Open Form 4 filing 0001209191-20-017016
2020-03-04 P, Open-market purchase NGM Biopharmaceuticals IncNGM 179,349, acquired Open Form 4 filing 0001209191-20-016365
2020-03-03 P, Open-market purchase NGM Biopharmaceuticals IncNGM 697,256, acquired Open Form 4 filing 0001209191-20-016365
2020-03-02 P, Open-market purchase NGM Biopharmaceuticals IncNGM 252,820, acquired Open Form 4 filing 0001209191-20-016365
2020-02-28 P, Open-market purchase NGM Biopharmaceuticals IncNGM 676,998, acquired Open Form 4 filing 0001209191-20-014196
2020-02-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 607,077, acquired Open Form 4 filing 0001209191-20-014196
2020-02-26 P, Open-market purchase NGM Biopharmaceuticals IncNGM 67,518, acquired Open Form 4 filing 0001209191-20-014196
2020-02-06 P, Open-market purchase NGM Biopharmaceuticals IncNGM 716,604, acquired Open Form 4 filing 0001209191-20-007975
2019-11-11 P, Open-market purchase NGM Biopharmaceuticals IncNGM 180, acquired Open Form 4 filing 0001209191-19-056436
2019-11-04 P, Open-market purchase NGM Biopharmaceuticals IncNGM 100,824, acquired Open Form 4 filing 0001209191-19-055551
2019-10-23 P, Open-market purchase NGM Biopharmaceuticals IncNGM 24,752, acquired Open Form 4 filing 0001209191-19-053938
2019-10-22 P, Open-market purchase NGM Biopharmaceuticals IncNGM 27,600, acquired Open Form 4 filing 0001209191-19-053938
2019-10-21 P, Open-market purchase NGM Biopharmaceuticals IncNGM 518,196, acquired Open Form 4 filing 0001209191-19-053734
2019-10-18 P, Open-market purchase NGM Biopharmaceuticals IncNGM 392,000, acquired Open Form 4 filing 0001209191-19-053734
2019-10-17 P, Open-market purchase NGM Biopharmaceuticals IncNGM 72,407, acquired Open Form 4 filing 0001209191-19-053734
2019-10-16 P, Open-market purchase NGM Biopharmaceuticals IncNGM 358,074, acquired Open Form 4 filing 0001209191-19-053345
2019-10-15 P, Open-market purchase NGM Biopharmaceuticals IncNGM 342,292, acquired Open Form 4 filing 0001209191-19-053345
2019-10-14 P, Open-market purchase NGM Biopharmaceuticals IncNGM 361,564, acquired Open Form 4 filing 0001209191-19-053345
2019-10-11 P, Open-market purchase NGM Biopharmaceuticals IncNGM 187,343, acquired Open Form 4 filing 0001347769-19-000018
2019-10-10 P, Open-market purchase NGM Biopharmaceuticals IncNGM 186,102, acquired Open Form 4 filing 0001347769-19-000018
2019-10-09 P, Open-market purchase NGM Biopharmaceuticals IncNGM 181,848, acquired Open Form 4 filing 0001347769-19-000018

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. COLUMN GROUP III GP, LP, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001790965

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.